Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : 'Do Not Take J & J Vaccine If You Have Taken Astrazeneca' - Health Minister Warns

07/28/2021 | 06:06am EDT

Health Minister Dr. Wilhemina Jallah has warned against taking the Johnson & Johnson Covid-19 vaccine for those who have already taken the Astrazeneca COVID-19 vaccine. According to her, research work are being done to discover the risk involved, so it is not advisable to take such risk.

She made the statement Sunday night at the Roberts International Airport (RIA) when Liberia received a donation of three hundred and two thousand four hundred (302,400) doses of Johnson & Johnson vaccines from the people and government of the United States of America.

The vaccines arrived on an SN Brussels 00.SFG aircraft.

Dr. Jallah told the press that the vaccine is a donation from the U.S. government and it didn't cost the government of Liberia any money. "We want to say thanks to the President and the people of the US for this gesture. This vaccine means a lot towards the fight against COVID-19," the minister said.

"These vaccines are for those who have never taken Covid-19 vaccine; if you have taken the vaccine please allow the others to take theirs. Do not take the J&J vaccine if you already started the Astrazeneca vaccine."

According to her, the vaccine will be rolled out in every county and nobody will be left out. She also announced that the government of Liberia is also expecting vaccines from Europe under the World Health Organization project.

Making the presentation on behalf of the US government, US Ambassador to Liberia, Michael McCarthy said, the donation of the vaccine is part of the U.S. government's pledge to initially provide at least 25 million of 80 million doses globally with Africa.

According to him, the U.S. government coordinated closely with the African Union and Africa Centers for Disease Control and Prevention on the Country allocations.

He said the vaccines will help protect the Liberian people from the ravages of the Covid-19 virus and reduce barriers to building back the Liberian economy. "We are proud to continue working together with the Liberian Government, the private sector, and civil society to do everything we can to mitigate the pandemic's high toll on life, livelihoods, and social impacts.

"To everyone who has not been vaccinated, I strongly encourage you to do so -as I did as so as you have the opportunity.

'The 302,400 doses are part of the Biden-Harris Administration commitment to share US vaccine supply with the world. As we continue to fight the COVID-19 pandemic at home and work to end the Pandemic worldwide, President Biden has promised that the United States will be an arsenal of vaccines for the world."

Copyright FrontPageAfrica. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.96% 8063 Delayed Quote.11.16%
JOHNSON & JOHNSON -0.49% 164.39 Delayed Quote.4.98%
All news about JOHNSON & JOHNSON
03:03pModerna Drops Ahead of FDA Committee COVID-19 Booster Decision
MT
01:21pCDC DATA : Moderna vaccine has edge in preventing COVID-19 hospitalizations
AQ
09:05aJOHNSON & JOHNSON : Slovenia starts mandatory vaccination for government workers
AQ
08:42aJOHNSON & JOHNSON : Janssen Presents Results from Phase 1b/2 NORSE Study in Pati..
PU
08:06aJOHNSON & JOHNSON : GSA Director Lauded for Luring More People to Get Covid-19 V..
AQ
08:00aJOHNSON & JOHNSON : Unit Janssen's Schizophrenia Drug Gets European Medicines Ag..
MT
06:06aJ&J's Janssen Gets CHMP Backing for Twice-Yearly Schizophrenia Treatment
DJ
09/16JOHNSON & JOHNSON : to Host Investor Conference Call on Third-Quarter Results
PR
09/16PFIZER : FDA Sees Current COVID-19 Vaccine Protocol as Still Effective Ahead of ..
MT
09/16Health Ministry - Four Covid-19 Vaccines Now Available in Sudan
AQ
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 407 M - -
Net income 2021 22 809 M - -
Net Debt 2021 1 880 M - -
P/E ratio 2021 19,1x
Yield 2021 2,52%
Capitalization 435 B 435 B -
EV / Sales 2021 4,63x
EV / Sales 2022 4,43x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 165,22 $
Average target price 185,83 $
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON4.98%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.21.62%249 329
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.84%209 456
ABBVIE INC.0.87%190 996